by S BIRRUNTHA/ pic by AFP
MALAYSIA is set to receive the delivery of 600,000 doses of AstraZeneca vaccines for Covid-19 in June this year, according to the Minister of Science, Technology and Innovation Khairy Jamaluddin.
He added that the country had previously signed a deal to receive 12.8 million doses of the two-dose AstraZeneca vaccine, in which 6.4 million doses from direct procurement that are manufactured in Thailand and also an additional 6.4 million doses through the Covid-19 vaccine global access (COVAX) facility under the World Health Organization (WHO).
“We will receive our first 600,000 doses of AstraZeneca in June, while the subsequent deliveries will then come every month,” he said in a virtual media briefing after launching the corporate collaboration ceremony for the National Covid-19 Immunisation Programme (PICK) today.
On another note, the minister assured that the country’s AstraZeneca vaccine supply from the COVAX facility under WHO would not be affected after India placed a temporary hold on all exports of the vaccine.
India’s largest vaccine manufacturer, the Serum Institute of India (SII) had delayed shipments of the AstraZeneca vaccine to several countries in recent days, including the United Kingdom (UK) and Brazil.
Commenting on this, Khairy said the country’s AstraZeneca supply from the COVAX facility comes from the manufacturer in South Korea namely, SK Bioscience and it does not come from SII.
“So, I don’t believe the ban from India will affect us unless there is something to do with the supply chain there.
“We are still waiting for the delivery details from COVAX. As far as I know it should not affect us,” he added.